An article titled “Tocilizumab Monotherapy Matches Methotrexate for QOL,” published Dec. 13, 2011, mischaracterized the study’s findings in the headline. Tocilizumab was studied with methotrexate against tocilizumab and placebo. In addition, quality of life was reported only as a secondary endpoint.
Copyright (c) 2010 Elsevier Global Medical News. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
